A detailed history of Degroof Petercam Asset Management transactions in Exact Sciences Corp stock. As of the latest transaction made, Degroof Petercam Asset Management holds 4,000 shares of EXAS stock, worth $198,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,000
Previous 4,000 -0.0%
Holding current value
$198,160
Previous $296 Million 6.65%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $236,240 - $302,880
4,000 New
4,000 $296 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.77B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Degroof Petercam Asset Management Portfolio

Follow Degroof Petercam Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Degroof Petercam Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Degroof Petercam Asset Management with notifications on news.